|ViroStat was founded in 1985 by Dr. Douglas McAllister to provide infectious disease antibody tools to researchers and manufacturers. These include the areas of virology, bacteriology and parasitology. The company offers more than 500 infectious disease reagents including their MONOTOPE™ monoclonal antibodies, OMNITOPE™ polyclonal antibodies and numerous recombinant antigens.|
New Product Information
NEW Antibodies for COVID-19 Virus Detection
The nucleocapsid of COVID-19 virus is ideal for antigen detection for two major reasons:
1) It is produced abundantly in infected cells
2) it is a highly conserved protein and therefore not prone to mutation.
The cytoplasm of infected cells fills with the nucleocapsid antigen. These cells can be collected on a NP swab and added to a specimen buffer to lyse and release this antigen for detection by immunoassay.
ViroStat has developed and just released a set of new monoclonal antibodies to the nucleocapsid of the COVID-19 virus. These final 5 antibodies were selected from an initial group of 60 based upon highest binding affinity and best ELISA pairing for detection of native viral antigen. Datasheet
Astrovirus Monoclonal Antibodies from Virostat
Astrovirus is a relatively newly discovered family of non-enveloped RNA viruses that cause gastroenteritis in animals and humans. Young children and the elderly are most susceptible due to underdeveloped or waning immune systems respectively. Symptoms include vomiting and diarrhea which can lead to dehydration. The virus can be detected in feces via PCR and immunoassay.
ViroStat has released a set of new Monoclonal Antibodies to Astrovirus. These antibodies are specific to the major capsid protein of the virus and form pairs for detecting this antigen. Datasheet
Please contact us for any inquiries, questions, or information requests.
Tokyo Future Style, Inc.